Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-02-12, Stock:PFE, The news for the past five days is as follows:
2019-02-05: NEWS1: Dow Rallies For Second Straight Triple-Digit Win.NEWS2: Dow Rallies For Second Straight Triple-Digit Win.NEWS3: Market Close Report: NASDAQ Composite index closes at 7,402.08 up 54.54 points.NEWS4: Market Close Report: NASDAQ Composite index closes at 7,402.08 up 54.54 points.NEWS5: Merck CEO Frazier to testify at Senate drug pricing hearing.NEWS6: Pharma execs will testify before Congress &apos;one way or another,&apos; US senator says.NEWS7: Pharma execs will testify before Congress 'one way or another,' US senator says.NEWS8: Lilly/Incyte's Olumiant Meets Endpoint in Eczema Studies.NEWS9: Lilly/Incyte's Olumiant Meets Endpoint in Eczema Studies.NEWS10: Health Care Sector Update for 02/05/2019: OPGN, CNC, GILD, JNJ, PFE, ABT, MRK, AMGN.NEWS11: Health Care Sector Update for 02/05/2019: OPGN, CNC, GILD, JNJ, PFE, ABT, MRK, AMGN.NEWS12: Lilly/Incyte's Olumiant Meets Endpoint in Eczema Studies.NEWS13: Corporate Profits' New Enemy Is the 'Dollar Vortex'.NEWS14: Here's Why Exact Sciences Soared 42.8% in January.NEWS15: Here's Why Exact Sciences Soared 42.8% in January.NEWS16: Here&apos;s Why Exact Sciences Soared 42.8% in January.
2019-02-06: NEWS1: At least four pharma CEOs to testify at Senate drug pricing hearing.NEWS2: Eli Lilly Stock Falls Because 2019 Isn’t 2018.NEWS3: At least four pharma CEOs to testify at Senate drug pricing hearing.NEWS4: Congress invites 7 drugmakers to testify at potentially hostile hearing on drug prices. Here's what they're saying.NEWS5: Health Care Sector Update for 02/06/2019: NVLN, AGLE, VNDA, JNJ, PFE, MRK, ABT, AMGN.NEWS6: Health Care Sector Update for 02/06/2019: NVLN, AGLE, VNDA, JNJ, PFE, MRK, ABT, AMGN.NEWS7: Pfizer CEO Bourla plans to testify at Senate drug pricing hearing.NEWS8: Winners & Losers from Trump's State of the Union Address.NEWS9: Winners & Losers from Trump's State of the Union Address.NEWS10: Cancer-Vaccine Maker BioNTech Considering an IPO in U.S..NEWS11: Winners & Losers from Trump's State of the Union Address.
2019-02-07: NEWS1: Glaxo (GSK) Beats on Q4 Earnings, to Focus on Oncology in '19.NEWS2: Glaxo (GSK) Beats on Q4 Earnings, to Focus on Oncology in '19.NEWS3: Health Care Sector Update for 02/07/2019: LCI, OSUR, CAH, JNJ, PFE, ABT, MRK, AMGN.NEWS4: Health Care Sector Update for 02/07/2019: LCI, OSUR, CAH, JNJ, PFE, ABT, MRK, AMGN.NEWS5: Glaxo (GSK) Beats on Q4 Earnings, to Focus on Oncology in '19.
2019-02-08: NEWS1: This Gene Therapy Stock Could Soon Hit The Auction Block — Here&apos;s Why.NEWS2: Notable ETF Inflow Detected - SPYG, GOOG, GOOGL, PFE.NEWS3: Notable ETF Inflow Detected - SPYG, GOOG, GOOGL, PFE.NEWS4: Pfizer Japan recalls high blood pressure drug over cancer-causing impurity.NEWS5: Health Care Sector Update for 02/08/2019: APOP, SGEN, MBOT, JNJ, PFE, ABT, MRK, AMGN.NEWS6: Health Care Sector Update for 02/08/2019: APOP, SGEN, MBOT, JNJ, PFE, ABT, MRK, AMGN.NEWS7: See what the IHS Markit Score report has to say about Pfizer Inc..NEWS8: Pharma Stock Roundup: Q4 Earnings at MRK, LLY, CHMP Nod for Several Drugs.NEWS9: Dow 30 Stock Roundup: Disney Earnings Impress, Pfizer's Cancer Drug Gets CHMP Nod.NEWS10: Pfizer Japan recalls high blood pressure drug Amvalo due to carcinogen.NEWS11: Buying the Dow Stocks With the Highest Dividends Is a Winning Strategy.NEWS12: What Solid Biosciences' First Failure Means for Sarepta Therapeutics.NEWS13: What Solid Biosciences' First Failure Means for Sarepta Therapeutics.
2019-02-11: NEWS1: FDA Accepts sBLA and Grants Priority Review for BAVENCIO® (avelumab) Plus INLYTA® (axitinib) for the Treatment of Advanced Renal Cell Carcinoma.NEWS2: After Hours Most Active for Feb 11, 2019 :  SNAP, BAC, ELAN, FDC, PFE, MGM, FOMX, EMB, FB, EBAY, JBLU, CELG.NEWS3: After Hours Most Active for Feb 11, 2019 :  SNAP, BAC, ELAN, FDC, PFE, MGM, FOMX, EMB, FB, EBAY, JBLU, CELG.NEWS4: Phase 3 ARCHES Trial Shows XTANDI® (enzalutamide) Significantly Improved Radiographic Progression-Free Survival in Men with Metastatic Hormone-Sensitive Prostate Cancer.NEWS5: Stocks Start Week of Trade Talks on Muted Note: Markets Wrap.NEWS6: Stocks making the biggest moves midday: Avis Budget Group, Pfizer, Tesla & more.NEWS7: Lilly to Begin Exchange Offer for Sale of Balance Elanco Stake.NEWS8: Lilly to Begin Exchange Offer for Sale of Balance Elanco Stake.NEWS9: See Which Of The Latest 13F Filers Holds Pfizer.NEWS10: See Which Of The Latest 13F Filers Holds Pfizer.NEWS11: Lilly to Begin Exchange Offer for Sale of Balance Elanco Stake.NEWS12: Dow 30 Stock Roundup: Disney Earnings Impress, Pfizer's Cancer Drug Gets CHMP Nod.NEWS13: Dow 30 Stock Roundup: Disney Earnings Impress, Pfizer's Cancer Drug Gets CHMP Nod.NEWS14: Pharma Stock Roundup: Q4 Earnings at MRK, LLY, CHMP Nod for Several Drugs.NEWS15: Pharma Stock Roundup: Q4 Earnings at MRK, LLY, CHMP Nod for Several Drugs.

Answer: Rise